Breast cancer is the most prevalent cancer among women in Western countries, and its prevalence is also increasing in Asia. The major risk factor for breast cancer can be traced to reproductive events that influence the lifetime levels of hormones. However, a large percentage of breast cancer cases cannot, be explained by these risk factors. The identification of susceptibility factors that predispose individuals to breast cancer (for instance, if they are exposed to particular environmental agents) could possibly give further insight into the etiology of this malignancy and provide targets for the future development of therapeutics. The most interesting candidate genes include those that mediate a range of functions. These include carcinogen metabolism, DNA repair, steroid hormone metabolism, signal transduction, and cell cycle control. :HFRQGXFWHGD KRVSLWDOEDVHG FDVHFRQWURO VWXG\ LQ 6RXWK .RUHD WR HYDOXDWH WKH SRWHQWLDO PRGLI\LQJ UROH RI WKH JHQHWLF SRO\PRUSKLVPVRIVHOHFWHGORZSHQHWUDQFHJHQHVWKDWDUH LQYROYHG LQ carcinogen metabolisms (i.e., CYP1A1, CYP2E1, GSTM1/T1/P1, NAT1/2, etc.), estrogen synthesis and metabolism (i.e., CYP19, CYP17, CYP1B1, COMT, ER-α, etc.), DNA repair (i.e., XRCC1/3, ERCC2/4, ATM, AGT, etc.), and signal transduction as well as others (i.e., TGF-β, IGF-1, TNF-β, IL-1B, IL-1RN, etc.). We also took into account the potential interaction between these and the known risk factors of breast cancer. The results of selected genes will be presented in this mini-review.
Introduction
Breast cancer is the most prevalent cancer among women in Western countries, and its prevalence is also increasing in Asia (Parkin et al., 1997; Yoo et al., 2002) . In 1994, the incidence rate of female breast cancer in Korean (adjusted for the world population) was 10.9 per 100,000, which was far lower than that of Western countries, and even lower than any other Asian country. The major risk factor for breast cancer can be traced to reproductive events that influence the lifetime levels of hormones (Feigelson and Henderson, 1996; Zhu and Conney, 1998) .
A large percentage of breast cancer cases cannot, however, be explained by these risk factors. The identification of susceptibility factors that predispose individuals to breast cancer (for example, if they are exposed to particular environmental agents) could possibly give further insight into the etiology of this malignancy. Inherited differences in the capacity to metabolize environmental carcinogens have recently been suggested to modify individual susceptibility to breast cancer. Therefore, the identification of new breast cancer susceptibility genes would yield new insight into breast tumorigenesis, and could provide targets for the future development of therapeutics.
In this respect, the most interesting candidate genes include those that mediate a range of functions. This includes carcinogen metabolism, DNA repair, steroid hormone metabolism, signal transduction, and cell cycle control. Although the relative risks of these low penetrance susceptibility genes to the development of breast cancer are generally lower than those from high penetrance susceptibility genes (e.g., BRCA1, BRCA2, etc.), the population attributable risk of low penetrance genes are much higher than those of the high penetrance gene since the frequency of variant alleles of low penetrance genes are higher in the general population. Therefore, higher public health significance rests on these low penetrance genes with the hope of obtaining more mechanistic insights into human breast carcinogenesis, as well as the targeted-preventive approaches to the individuals with at risk *To whom correspondence should be addressed. genotypes.
We conducted a hospital-based case-control study in South Korea to further evaluate the potential modifying role of the genetic polymorphisms of selected genes that are involved in carcinogen metabolisms, estrogen metabolism, signal transduction, and DNA repair. We also took into account the potential interaction between these and the known risk factors of breast cancer (Table 1) . The results of the selected genes will be presented in this mini-review.
GSTM1 and T1
The inherited metabolic capacity of glutathione S-transferases (GSTs) have been related to the individual breast cancer risk (Helzlsouer et al., 1998) . GSTs are a superfamily of enzymes that are involved in conjugation with reactive intermediates to soluble glutathione, and therefore, play an important role in the detoxification of endogenous and exogenous toxicants. GSTM1 can detoxify carcinogenic polycyclic aromatic hydrocarbons (PAHs), such as benzo[a]pyrene (BaP) and mycotoxin aflatoxin, while GSTT1 can detoxify smaller reactive hydrocarbons, such as ethylene oxide and diepoxybutane. It can also metabolize solvents. GSTs may also have a role in the metabolism of lipid and DNA products of oxidative stress (Zhu and Conney, 1998) . About half of the Asian population lacks GSTM1 and GSTT1 enzyme activities, due to homozygous deletions of the respective genes.
In our study (Park et al., 2000) , for the GSTM1 null genotype, a statistically significant effect was observed among the premenopausal women (OR = 2.0, 95% CI = 1.1-3.7); whereas, the significant effect of GSTT1 null genotype (OR = 1.6, 95% CI = 1.0-2.5) in all of the study subjects was mainly attributable to the premenopausal women group (OR = 1.7, 95% CI = 0.9-3.2) ( Table 2 ). When the potential combined effect of the GSTM1 and GSTT1 genotypes was examined, then the concurrent lack of both of the genes posed more than a two-fold risk of breast cancer (OR = 2.2, 95% CI = 1.1-4.5) ( Table 3 ). The most remarkable risk was seen after stratification by the menopausal status at the time of diagnosis; among alcohol-consuming premenopausal women, the concurrent lack of both the GSTM1 and GSTT1 genes resulted in more than a five-fold risk of breast cancer (OR = 5.3, 95% CI = 1.0-27.8) (Table 4) .
COMT
Catechol O-methyltransferase (COMT) is one of the key enzymes that are involved in the metabolism of catecholamine in humans. The presumed mechanisms of catechol estrogen in breast carcinogenesis were recently reviewed by Zhu and Conney (1998) . Catechol estrogen causes DNA damage either directly, or through its quinone metabolites (Yager and Liehr, 1996) . In our study (Yim et al., 2001) , the subjects with at least one COMT-L allele had an almost two-fold risk of breast cancer when compared with the COMT-HH genotype individuals (OR = 1.7, 95% CI = 1.04-2.78) ( Table 5) . P for trend in ever-drinker < 0.05 P-value for interaction; P = 0.02 for premenopausal women, P = 0.08 for postmenopausal women. These P-values for interaction are not changed after adjustment for body mass index. (52) 42 (46) 02 (02) 059 (65) 023 (25) 009 (10) 1.0 (ref. (52) 44 (48) 059 (65) 032 (35) 1.0 (ref.) 1.7 (0.95-3.13) *OR; odds ratio, 95% CI; 95% confidence interval of odds ratio. The ORs were adjusted for education, age at menarche, age at first pregnancy, number of live birth baby, duration of breast feeding, smoking, drinking, body mass index and family history of breast cancer. , the XRCC1 codon 194 polymorphism did not influence the breast cancer risk; whereas, homozygosity for the codon 399 Gln allele placed women at a 2.4-fold risk (95% CI = 1.20-4.72) for this malignancy; the risk increased to 3.8-fold (95% CI = 1.44-10.30) in the premenopausal women. The risk of breast cancer increased with the number of Gln alleles (P for trend = 0.02) ( Table 8) .
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Conclusions
Breast cancer is the second most frequent cancer in Korean women, and the incidence is increasing in both Western countries and Korea. Although a substantial proportion of breast cancer cases are explained by well-established risk factors (i.e., later age at first pregnancy, nulliparity, and firstdegree family history of breast cancer), the reason for the observed worldwide increase in breast cancer incidences is still largely unknown. The molecular epidemiological approaches using the genetic information in a populationbased observational study will provide better mechanistic insights of breast cancer etiology, as well as efficient preventive measures to genetically susceptible population in the future. The ORs were adjusted for age, education, body mass index, age at menarche, age at first pregnancy, age at menopause, smoking, alcohol consumption, duration of breast feeding, family history of breast cancer, and menopausal status at baseline.
